BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Thiethylperazine

A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457)

165+ PubMed studies analyzed · 12 RCTs · Evidence Score: 46.4

Research Domains

Thiethylperazine has been studied across 15 research domains including 🔬 Oncology, ✨ Skin & Hair, 🧠 Neuroprotection, 😴 Sleep, 🧠 Focus & Attention. The primary research focus is 🔬 Oncology with 9% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Thiethylperazine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Oxyfedrine
9 shared targets
Nebivolol
12 shared targets
Aprindine
8 shared targets
Dimethindene
8 shared targets
Meclizine
12 shared targets
Cabergoline
12 shared targets
Nylidrin
10 shared targets
Dihydroergocornine
8 shared targets
ebastine
13 shared targets
Benzethonium
15 shared targets
Loading evidence profile...

This evidence profile for Thiethylperazine is generated deterministically from 165 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.